| ZMN | Name: | 4-(5-bromofuran-2-carbonyl)-N-[3-(3-methylphenoxy)propyl]piperazine-1-carboxamide | Formula: | C20 H24 Br N3 O4 | SMILES: | O=C(N1CCN(CC1)C(=O)NCCCOc1cc(C)ccc1)c1ccc(Br)o1 | InChi: | InChI=1S/C20H24BrN3O4/c1-15-4-2-5-16(14-15)27-13-3-8-22-20(26)24-11-9-23(10-12-24)19(25)17-6-7-18(21)28-17/h2,4-7,14H,3,8-13H2,1H3,(H,22,26) | Definition date: | 2023-03-16 | Last modified: | 2023-03-24 | Release date: | 2023-03-29 | Identifier: | 4-(5-bromofuran-2-carbonyl)-N-[3-(3-methylphenoxy)propyl]piperazine-1-carboxamide |
|
| ZMW | Name: | N-benzyl-4-(furan-2-carbonyl)piperazine-1-carboxamide | Formula: | C17 H19 N3 O3 | SMILES: | O=C(N1CCN(CC1)C(=O)NCc1ccccc1)c1ccco1 | InChi: | InChI=1S/C17H19N3O3/c21-16(15-7-4-12-23-15)19-8-10-20(11-9-19)17(22)18-13-14-5-2-1-3-6-14/h1-7,12H,8-11,13H2,(H,18,22) | Definition date: | 2023-03-16 | Last modified: | 2023-03-24 | Release date: | 2023-03-29 | Identifier: | N-benzyl-4-(furan-2-carbonyl)piperazine-1-carboxamide |
|
| U7R | Name: | (4P,6M)-6-[1-(2-fluoroethyl)-1H-1,2,3-triazol-4-yl]-4-[5-(methanesulfonyl)-2-methoxyphenyl]-2-methylisoquinolin-1(2H)-one | Formula: | C22 H21 F N4 O4 S | SMILES: | FCCn1cc(nn1)c1ccc2C(=O)N(C)C=C(c3cc(ccc3OC)S(C)(=O)=O)c2c1 | InChi: | InChI=1S/C22H21FN4O4S/c1-26-12-19(18-11-15(32(3,29)30)5-7-21(18)31-2)17-10-14(4-6-16(17)22(26)28)20-13-27(9-8-23)25-24-20/h4-7,10-13H,8-9H2,1-3H3 | Definition date: | 2022-08-10 | Last modified: | 2023-03-24 | Release date: | 2023-03-29 | Identifier: | (4P,6M)-6-[1-(2-fluoroethyl)-1H-1,2,3-triazol-4-yl]-4-[5-(methanesulfonyl)-2-methoxyphenyl]-2-methylisoquinolin-1(2H)-one |
|
| WRQ | Name: | N-{[(4,6-dimethoxypyrimidin-2-yl)carbamoyl]sulfamoyl}-N-methylmethanesulfonamide | Formula: | C9 H15 N5 O7 S2 | SMILES: | O=C(Nc1nc(cc(OC)n1)OC)NS(=O)(=O)N(C)S(C)(=O)=O | InChi: | InChI=1S/C9H15N5O7S2/c1-14(22(4,16)17)23(18,19)13-9(15)12-8-10-6(20-2)5-7(11-8)21-3/h5H,1-4H3,(H2,10,11,12,13,15) | Definition date: | 2022-10-17 | Last modified: | 2023-03-24 | Release date: | 2023-03-29 | Identifier: | N-{[(4,6-dimethoxypyrimidin-2-yl)carbamoyl]sulfamoyl}-N-methylmethanesulfonamide |
|
| ZNX | Name: | N-(4-methoxyphenyl)-4-(5-methylfuran-2-carbonyl)piperazine-1-carboxamide | Formula: | C18 H21 N3 O4 | SMILES: | Cc1ccc(o1)C(=O)N1CCN(CC1)C(=O)Nc1ccc(OC)cc1 | InChi: | InChI=1S/C18H21N3O4/c1-13-3-8-16(25-13)17(22)20-9-11-21(12-10-20)18(23)19-14-4-6-15(24-2)7-5-14/h3-8H,9-12H2,1-2H3,(H,19,23) | Definition date: | 2023-03-17 | Last modified: | 2023-03-24 | Release date: | 2023-03-29 | Identifier: | N-(4-methoxyphenyl)-4-(5-methylfuran-2-carbonyl)piperazine-1-carboxamide |
|
| ZO5 | Name: | N-[(2H-1,3-benzodioxol-5-yl)methyl]-4-(furan-2-carbonyl)piperazine-1-carboxamide | Formula: | C18 H19 N3 O5 | SMILES: | O=C(N1CCN(CC1)C(=O)NCc1ccc2OCOc2c1)c1ccco1 | InChi: | InChI=1S/C18H19N3O5/c22-17(15-2-1-9-24-15)20-5-7-21(8-6-20)18(23)19-11-13-3-4-14-16(10-13)26-12-25-14/h1-4,9-10H,5-8,11-12H2,(H,19,23) | Definition date: | 2023-03-17 | Last modified: | 2023-03-24 | Release date: | 2023-03-29 | Identifier: | N-[(2H-1,3-benzodioxol-5-yl)methyl]-4-(furan-2-carbonyl)piperazine-1-carboxamide |
|
| ZOH | Name: | (2R)-4-(furan-3-carbonyl)-N-(4-methoxyphenyl)-2-methylpiperazine-1-carboxamide | Formula: | C18 H21 N3 O4 | SMILES: | O=C(N1CCN(C(=O)Nc2ccc(OC)cc2)C(C)C1)c1ccoc1 | InChi: | InChI=1S/C18H21N3O4/c1-13-11-20(17(22)14-7-10-25-12-14)8-9-21(13)18(23)19-15-3-5-16(24-2)6-4-15/h3-7,10,12-13H,8-9,11H2,1-2H3,(H,19,23)/t13-/m1/s1 | Definition date: | 2023-03-17 | Last modified: | 2023-03-24 | Release date: | 2023-03-29 | Identifier: | (2R)-4-(furan-3-carbonyl)-N-(4-methoxyphenyl)-2-methylpiperazine-1-carboxamide |
|
| WSF | Name: | (2R)-3-{[(S)-hydroxy(3-methylbutoxy)phosphoryl]oxy}-2-(octanoyloxy)propyl decanoate | Formula: | C26 H51 O8 P | SMILES: | O=C(OC(COP(O)(=O)OCCC(C)C)COC(=O)CCCCCCCCC)CCCCCCC | InChi: | InChI=1S/C26H51O8P/c1-5-7-9-11-12-14-15-17-25(27)31-21-24(34-26(28)18-16-13-10-8-6-2)22-33-35(29,30)32-20-19-23(3)4/h23-24H,5-22H2,1-4H3,(H,29,30)/t24-/m1/s1 | Definition date: | 2022-10-17 | Last modified: | 2023-03-24 | Release date: | 2023-03-29 | Identifier: | (2R)-3-{[(S)-hydroxy(3-methylbutoxy)phosphoryl]oxy}-2-(octanoyloxy)propyl decanoate |
|
| ZOK | Name: | (2S)-4-(furan-2-carbonyl)-2-methyl-N-(2,2,2-trifluoroethyl)piperazine-1-carboxamide | Formula: | C13 H16 F3 N3 O3 | SMILES: | O=C(N1CCN(C(=O)NCC(F)(F)F)C(C)C1)c1ccco1 | InChi: | InChI=1S/C13H16F3N3O3/c1-9-7-18(11(20)10-3-2-6-22-10)4-5-19(9)12(21)17-8-13(14,15)16/h2-3,6,9H,4-5,7-8H2,1H3,(H,17,21)/t9-/m0/s1 | Definition date: | 2023-03-17 | Last modified: | 2023-03-24 | Release date: | 2023-03-29 | Identifier: | (2S)-4-(furan-2-carbonyl)-2-methyl-N-(2,2,2-trifluoroethyl)piperazine-1-carboxamide |
|
| U93 | Name: | (2~{S})-2-[[(~{R})-[[(5~{S})-5-azanyl-6-oxidanylidene-hexyl]amino]-[2-methyl-3-oxidanyl-5-(phosphonooxymethyl)pyridin-4-yl]methyl]amino]-3-phosphonooxy-propanoic acid | Formula: | C17 H30 N4 O12 P2 | SMILES: | Cc1ncc(CO[P](O)(O)=O)c([CH](NCCCC[CH](N)C=O)N[CH](CO[P](O)(O)=O)C(O)=O)c1O | InChi: | InChI=1S/C17H30N4O12P2/c1-10-15(23)14(11(6-20-10)8-32-34(26,27)28)16(19-5-3-2-4-12(18)7-22)21-13(17(24)25)9-33-35(29,30)31/h6-7,12-13,16,19,21,23H,2-5,8-9,18H2,1H3,(H,24,25)(H2,26,27,28)(H2,29,30,31)/t12-,13-,16+/m0/s1 | Definition date: | 2023-01-30 | Last modified: | 2023-03-24 | Release date: | 2023-03-29 | Identifier: | (2~{S})-2-[[(~{R})-[[(5~{S})-5-azanyl-6-oxidanylidene-hexyl]amino]-[2-methyl-3-oxidanyl-5-(phosphonooxymethyl)pyridin-4-yl]methyl]amino]-3-phosphonooxy-propanoic acid |
|
| ZOU | Name: | 4-(furan-2-carbonyl)-N-(2-methoxy-5-methylphenyl)piperazine-1-carboxamide | Formula: | C18 H21 N3 O4 | SMILES: | O=C(N1CCN(CC1)C(=O)Nc1cc(C)ccc1OC)c1ccco1 | InChi: | InChI=1S/C18H21N3O4/c1-13-5-6-15(24-2)14(12-13)19-18(23)21-9-7-20(8-10-21)17(22)16-4-3-11-25-16/h3-6,11-12H,7-10H2,1-2H3,(H,19,23) | Definition date: | 2023-03-17 | Last modified: | 2023-03-24 | Release date: | 2023-03-29 | Identifier: | 4-(furan-2-carbonyl)-N-(2-methoxy-5-methylphenyl)piperazine-1-carboxamide |
|
| ZP0 | Name: | N-{[(2S)-5,5-dimethyl-1,4-dioxan-2-yl]methyl}-4-(3-hydroxybenzoyl)piperazine-1-carboxamide | Formula: | C19 H27 N3 O5 | SMILES: | Oc1cccc(c1)C(=O)N1CCN(CC1)C(=O)NCC1OCC(C)(C)OC1 | InChi: | InChI=1S/C19H27N3O5/c1-19(2)13-26-16(12-27-19)11-20-18(25)22-8-6-21(7-9-22)17(24)14-4-3-5-15(23)10-14/h3-5,10,16,23H,6-9,11-13H2,1-2H3,(H,20,25)/t16-/m0/s1 | Definition date: | 2023-03-17 | Last modified: | 2023-03-24 | Release date: | 2023-03-29 | Identifier: | N-{[(2S)-5,5-dimethyl-1,4-dioxan-2-yl]methyl}-4-(3-hydroxybenzoyl)piperazine-1-carboxamide |
|
| ZP5 | Name: | 4-(furan-2-carbonyl)-N-(1,2-oxazol-3-yl)piperazine-1-carboxamide | Formula: | C13 H14 N4 O4 | SMILES: | O=C(Nc1ccon1)N1CCN(CC1)C(=O)c1ccco1 | InChi: | InChI=1S/C13H14N4O4/c18-12(10-2-1-8-20-10)16-4-6-17(7-5-16)13(19)14-11-3-9-21-15-11/h1-3,8-9H,4-7H2,(H,14,15,19) | Definition date: | 2023-03-17 | Last modified: | 2023-03-24 | Release date: | 2023-03-29 | Identifier: | 4-(furan-2-carbonyl)-N-(1,2-oxazol-3-yl)piperazine-1-carboxamide |
|
| ZPB | Name: | N-(propan-2-yl)-4-(thiophene-2-carbonyl)piperazine-1-carboxamide | Formula: | C13 H19 N3 O2 S | SMILES: | O=C(N1CCN(CC1)C(=O)NC(C)C)c1cccs1 | InChi: | InChI=1S/C13H19N3O2S/c1-10(2)14-13(18)16-7-5-15(6-8-16)12(17)11-4-3-9-19-11/h3-4,9-10H,5-8H2,1-2H3,(H,14,18) | Definition date: | 2023-03-17 | Last modified: | 2023-03-24 | Release date: | 2023-03-29 | Identifier: | N-(propan-2-yl)-4-(thiophene-2-carbonyl)piperazine-1-carboxamide |
|
| ZPL | Name: | N-[2-(4,5-dimethyl-1,3-thiazol-2-yl)ethyl]-4-(thiophene-2-carbonyl)piperazine-1-carboxamide | Formula: | C17 H22 N4 O2 S2 | SMILES: | O=C(c1cccs1)N1CCN(CC1)C(=O)NCCc1nc(C)c(C)s1 | InChi: | InChI=1S/C17H22N4O2S2/c1-12-13(2)25-15(19-12)5-6-18-17(23)21-9-7-20(8-10-21)16(22)14-4-3-11-24-14/h3-4,11H,5-10H2,1-2H3,(H,18,23) | Definition date: | 2023-03-17 | Last modified: | 2023-03-24 | Release date: | 2023-03-29 | Identifier: | N-[2-(4,5-dimethyl-1,3-thiazol-2-yl)ethyl]-4-(thiophene-2-carbonyl)piperazine-1-carboxamide |
|
| ZQ0 | Name: | N-butyl-4-(5-methylfuran-2-carbonyl)piperazine-1-carboxamide | Formula: | C15 H23 N3 O3 | SMILES: | Cc1ccc(o1)C(=O)N1CCN(CC1)C(=O)NCCCC | InChi: | InChI=1S/C15H23N3O3/c1-3-4-7-16-15(20)18-10-8-17(9-11-18)14(19)13-6-5-12(2)21-13/h5-6H,3-4,7-11H2,1-2H3,(H,16,20) | Definition date: | 2023-03-17 | Last modified: | 2023-03-24 | Release date: | 2023-03-29 | Identifier: | N-butyl-4-(5-methylfuran-2-carbonyl)piperazine-1-carboxamide |
|
| ZQ5 | Name: | N-butyl-4-(thiophene-2-carbonyl)piperazine-1-carboxamide | Formula: | C14 H21 N3 O2 S | SMILES: | O=C(N1CCN(CC1)C(=O)NCCCC)c1cccs1 | InChi: | InChI=1S/C14H21N3O2S/c1-2-3-6-15-14(19)17-9-7-16(8-10-17)13(18)12-5-4-11-20-12/h4-5,11H,2-3,6-10H2,1H3,(H,15,19) | Definition date: | 2023-03-17 | Last modified: | 2023-03-24 | Release date: | 2023-03-29 | Identifier: | N-butyl-4-(thiophene-2-carbonyl)piperazine-1-carboxamide |
|
| ZQ9 | Name: | 4-(thiophene-2-carbonyl)-N-[(thiophen-2-yl)methyl]piperazine-1-carboxamide | Formula: | C15 H17 N3 O2 S2 | SMILES: | O=C(NCc1cccs1)N1CCN(CC1)C(=O)c1cccs1 | InChi: | InChI=1S/C15H17N3O2S2/c19-14(13-4-2-10-22-13)17-5-7-18(8-6-17)15(20)16-11-12-3-1-9-21-12/h1-4,9-10H,5-8,11H2,(H,16,20) | Definition date: | 2023-03-17 | Last modified: | 2023-03-24 | Release date: | 2023-03-29 | Identifier: | 4-(thiophene-2-carbonyl)-N-[(thiophen-2-yl)methyl]piperazine-1-carboxamide |
|
| Y88 | Name: | 6-[4-({4-[(2R)-1,1,1-trifluoropropan-2-yl]phenyl}acetyl)piperazin-1-yl]pyridazine-3-carbonitrile | Formula: | C20 H20 F3 N5 O | SMILES: | O=C(Cc1ccc(cc1)C(C)C(F)(F)F)N1CCN(CC1)c1ccc(C#N)nn1 | InChi: | InChI=1S/C20H20F3N5O/c1-14(20(21,22)23)16-4-2-15(3-5-16)12-19(29)28-10-8-27(9-11-28)18-7-6-17(13-24)25-26-18/h2-7,14H,8-12H2,1H3/t14-/m1/s1 | Definition date: | 2022-04-01 | Last modified: | 2023-03-24 | Release date: | 2023-03-29 | Identifier: | 6-[4-({4-[(2R)-1,1,1-trifluoropropan-2-yl]phenyl}acetyl)piperazin-1-yl]pyridazine-3-carbonitrile |
|
| Y89 | Name: | 1-[4-(6-chloropyridazin-3-yl)piperazin-1-yl]-2-(4-cyclopropylphenyl)ethan-1-one | Formula: | C19 H21 Cl N4 O | SMILES: | O=C(Cc1ccc(cc1)C1CC1)N1CCN(CC1)c1ccc(Cl)nn1 | InChi: | InChI=1S/C19H21ClN4O/c20-17-7-8-18(22-21-17)23-9-11-24(12-10-23)19(25)13-14-1-3-15(4-2-14)16-5-6-16/h1-4,7-8,16H,5-6,9-13H2 | Definition date: | 2022-04-01 | Last modified: | 2023-03-24 | Release date: | 2023-03-29 | Identifier: | 1-[4-(6-chloropyridazin-3-yl)piperazin-1-yl]-2-(4-cyclopropylphenyl)ethan-1-one |
|
| Y7R | Name: | (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl acetate | Formula: | C17 H28 O2 | SMILES: | CC(=O)OCC=C(/C)CCC=C(/C)CCC=C(/C)C | InChi: | InChI=1S/C17H28O2/c1-14(2)8-6-9-15(3)10-7-11-16(4)12-13-19-17(5)18/h8,10,12H,6-7,9,11,13H2,1-5H3/b15-10+,16-12+ | Synonyms: | (2E,6E)-farnesyl acetate | Definition date: | 2023-02-22 | Last modified: | 2023-03-24 | Release date: | 2023-03-29 | Identifier: | (2E,6E)-3,7,11-trimethyldodeca-2,6,10-trien-1-yl acetate |
|
| Y90 | Name: | 6-{4-[(4-cyclopropyl-2-fluorophenyl)acetyl]piperazin-1-yl}pyridazine-3-carbonitrile | Formula: | C20 H20 F N5 O | SMILES: | O=C(Cc1ccc(cc1F)C1CC1)N1CCN(CC1)c1ccc(C#N)nn1 | InChi: | InChI=1S/C20H20FN5O/c21-18-11-15(14-1-2-14)3-4-16(18)12-20(27)26-9-7-25(8-10-26)19-6-5-17(13-22)23-24-19/h3-6,11,14H,1-2,7-10,12H2 | Definition date: | 2022-04-01 | Last modified: | 2023-03-24 | Release date: | 2023-03-29 | Identifier: | 6-{4-[(4-cyclopropyl-2-fluorophenyl)acetyl]piperazin-1-yl}pyridazine-3-carbonitrile |
|
| Y92 | Name: | 1-[4-(6-chloropyridazin-3-yl)piperazin-1-yl]-2-(4-cyclopropyl-3-fluorophenyl)ethan-1-one | Formula: | C19 H20 Cl F N4 O | SMILES: | O=C(Cc1ccc(C2CC2)c(F)c1)N1CCN(CC1)c1ccc(Cl)nn1 | InChi: | InChI=1S/C19H20ClFN4O/c20-17-5-6-18(23-22-17)24-7-9-25(10-8-24)19(26)12-13-1-4-15(14-2-3-14)16(21)11-13/h1,4-6,11,14H,2-3,7-10,12H2 | Definition date: | 2022-04-01 | Last modified: | 2023-03-24 | Release date: | 2023-03-29 | Identifier: | 1-[4-(6-chloropyridazin-3-yl)piperazin-1-yl]-2-(4-cyclopropyl-3-fluorophenyl)ethan-1-one |
|
| Y93 | Name: | 1-[(2R)-4-(6-chloropyridazin-3-yl)-2-methylpiperazin-1-yl]-2-(4-cyclopropylphenyl)ethan-1-one | Formula: | C20 H23 Cl N4 O | SMILES: | O=C(Cc1ccc(cc1)C1CC1)N1CCN(CC1C)c1ccc(Cl)nn1 | InChi: | InChI=1S/C20H23ClN4O/c1-14-13-24(19-9-8-18(21)22-23-19)10-11-25(14)20(26)12-15-2-4-16(5-3-15)17-6-7-17/h2-5,8-9,14,17H,6-7,10-13H2,1H3/t14-/m1/s1 | Definition date: | 2022-04-01 | Last modified: | 2023-03-24 | Release date: | 2023-03-29 | Identifier: | 1-[(2R)-4-(6-chloropyridazin-3-yl)-2-methylpiperazin-1-yl]-2-(4-cyclopropylphenyl)ethan-1-one |
|
| Y99 | Name: | 6-[4-({4-[(2S)-1,1,1-trifluoropropan-2-yl]phenyl}acetyl)piperazin-1-yl]pyridazine-3-carbonitrile | Formula: | C20 H20 F3 N5 O | SMILES: | O=C(Cc1ccc(cc1)C(C)C(F)(F)F)N1CCN(CC1)c1ccc(C#N)nn1 | InChi: | InChI=1S/C20H20F3N5O/c1-14(20(21,22)23)16-4-2-15(3-5-16)12-19(29)28-10-8-27(9-11-28)18-7-6-17(13-24)25-26-18/h2-7,14H,8-12H2,1H3/t14-/m0/s1 | Definition date: | 2022-04-11 | Last modified: | 2023-03-24 | Release date: | 2023-03-29 | Identifier: | 6-[4-({4-[(2S)-1,1,1-trifluoropropan-2-yl]phenyl}acetyl)piperazin-1-yl]pyridazine-3-carbonitrile |
|